Alimentiv is an industry-leading specialty GI contract research organization (CRO) transforming clinical trial outcomes by combining deep GI expertise, advanced medical imaging solutions, and cutting-edge precision medicine. With a global network of 5,000+ sites in over 60 countries, Alimentiv offers tailored end-to-end solutions for clinical research needs, including medical imaging, precision medicine, biomarker discovery, and histopathology. Headquartered in London, Ontario, the company supports over 70% of all IBD compounds in development, delivering efficient and impactful clinical trials.